23
Glory Health Industry Limited
2329.HK · HKSE
$0.10 +3.26% (+$0.00)
1M -10.38%
Market Cap ¥341.8M
P/E Ratio -
Div. Yield -
ROE 20.52%
Bulios Fair Price
$0.13
36.8% upside
Current Price
$0.095
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 2329.HK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
91 /100
Cheap P/S 0.33x
P/FCF 22.50x
P/B 0.04x
Growth
0 /100
Declining Rev. growth 35.75%
Book val. growth 11.58%
FCF growth 66.76%
Profitability
5 /100
Weak Gross margin 29.75%
FCF margin 1.47%
Net margin 175.98%
Quality
0 /100
Poor ROIC 1.45%
Asset turnover 0.02x
ROE 20.52%
Debt
35 /100
Moderate Debt/Equity 2.94x
Debt/Assets 0.42x
Current ratio 0.68x
Stability
25 /100
Unstable Beta 0.38x
Profitable years 0
Rev. volatility 35.21%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 2329.HK
Online
Sector
Real Estate
Industry
Real Estate - Development
CEO
Zhangsun Zhang
Employees
319
Headquarters
Beijing